Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fluorodeoxyglucose f18

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fluorodeoxyglucose f18 in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(fluorodeoxyglucose f18)
Trials
(fluorodeoxyglucose f18)
Recent Studies (post-2010) (fluorodeoxyglucose f18)
9,15618755234,7712,16020,111

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Moliner, P; Maziere, B; Ottaviani, M; Remy, P; Samson, Y1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fluorodeoxyglucose f18

ArticleYear
Effect of alpha-glyceril-phosphorylcholine on cerebral glucose metabolism in normal volunteers.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Brain; Brain Chemistry; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Parasympathomimetics; Phosphorylcholine; Platelet Activating Factor; Tomography, Emission-Computed

1992